secwatch.observer — SEC 8-K summary
======================================

Issuer:     ENDRA Life Sciences Inc. (NDRA)
CIK:        0001681682
Form:       8-K
Filed at:   2023-08-10T23:59:59+00:00
Accession:  0001654954-23-010417
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

ENDRA Life Sciences annual meeting elects directors, approves say-on-pay frequency of 1 year
--------------------------------------------------------------------------------

- All five director nominees elected: Michelon (2,024,988 for), Basenese (1,628,081), DiGiandomenico (1,976,138), Harsh (1,958,901), Tokman (2,054,532).
- Say-on-pay approved with 80% of votes cast in favor (1,733,406 for, 340,392 against, 71,792 abstain).
- Stockholders recommend say-on-pay every 1 year (1,743,563 votes); board adopts annual frequency until next required vote in 6 years.
- RBSM LLP ratified as independent auditor for FY2023 with 94% of votes for (2,794,638 for, 126,032 against, 63,296 abstain).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1681682/000165495423010417/0001654954-23-010417-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1681682/000165495423010417/ndra_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-23-010417

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer